close Video Employers mandating vaccines for workers becoming more widespread Fox News contributor Jonathon Turley weighs in on vaccine mandates on ‘Your World’ AstraZeneca said Thursday that it intends to seek U.S. authorization for its COVID-19 vaccine in the second half of this year, offering a new timetable for the much-delayed application. CLICK HERE TO FIND A COVID-19 VACCINE NEAR YOU The Anglo-Swedish drugmaker announced the schedule as it released second-quarter financial results, which showed that the company and its sub-licensees delivered more than 700 million doses of the vaccine to over 170 countries in the first half of this year. That includes 80 million doses that went to the COVAX initiative for low- and middle-income countries. The news on the U.S. filing is being closely watched, as the timeframe has slipped. ASTRAZENECA FINDS SMALL CLOT RISK AFTER 1ST SHOT When AstraZeneca released data from its U.S. trial of the vaccine on March 22, company officials said they expected to seek authorization from the Food and Drug Administration in the first half of April. In April, the company said it expected to submit a U.S. application in the “coming weeks.” The U.K., European Union and World Health Organization have already… Read full this story
- Japan to transfer Covid-19 vaccine production technologies to Vietnam
- In boost for Africa, Senegal aims to make Covid-19 vaccines next year
- World Health Organization authorizes China's Sinovac Covid-19 vaccine for emergency use
- TRACKER: Which COVID-19 vaccines are being eyed by the Philippines?
- AstraZeneca COVID-19 vaccine linked to 'very small’ increased risk of bleeding, study says
- Businesses face difficulties in vaccine imports
- Bill Gates, the Virus and the Quest to Vaccinate the World
- AstraZeneca’s Coronavirus Vaccine, Easy and Cheap to Produce, Appears Effective
- Mexico Adds Over 4,200 to COVID-19 Death Total, Admits Virus Deaths Likely Higher
- Novavax Vaccine Updates: U.S. Phase 3 Data, Efficacy Against Beta Variant
- 'Moderna Vaccine 100 Per Cent Effective In Severe Cases', Company To Apply For Emergency Authorization Soon
- German CureVac COVID Vaccine Only 47 Percent Effective, 3 Percent Below Accepted Threshold
AstraZeneca to seek US approval for COVID-19 vaccine in second half have 327 words, post on www.foxnews.com at July 29, 2021. This is cached page on Konitono. If you want remove this page, please contact us.